Crinetics Pharmaceuticals granted 39,575 stock options and 26,525 RSU awards to 9 new non-executive employees on Dec 10, 2025.
On December 10, 2025, Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) disclosed that the Compensation Committee of the Board of Directors sanctioned non-qualified stock option grants for the acquisition of 39,575 common stock shares and awarded 26,525 restricted stock unit ("RSU") offerings to 9 fresh non-executive staff members. These grants were made under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”), in adherence to Nasdaq Listing Rule 5635(c)(4) for employees newly hired by Crinetics.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments